This inventor holds 1 USPTO granted patent. Top assignees: Emory University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014.
Company Filing History:
1 out of 1,024 
1 out of 3,693 
Years Active: 2014
Title: Suraj Sable: Innovator in Vaccine Development
Introduction
Suraj Sable is a notable inventor based in Atlanta, GA, who has made significant contributions to the field of immunology. He is recognized for his innovative work in developing a polypeptide vaccine aimed at combating mycobacterial infections. His research focuses on eliciting robust immune responses to enhance disease prevention.
Latest Patents
Suraj Sable holds a patent for a polypeptide vaccine and vaccination strategy against mycobacterium. This vaccine is designed to be administered in conjunction with the BCG vaccine, utilizing a prime-boost strategy to maximize immunoprotection. The goal of this innovative approach is to achieve effective prevention or elimination of disease in subjects. The pharmaceutical package associated with this vaccine ensures that it elicits the desired immunoprotection when administered.
Career Highlights
Throughout his career, Suraj Sable has worked with prestigious institutions such as Emory University and the National Institutes of Health, which is a component of the US Department of Health & Human Services. His work in these organizations has allowed him to contribute to significant advancements in vaccine research and development.
Collaborations
Suraj has collaborated with esteemed colleagues, including Bonnie B Plikaytis and Thomas M Shinnick. These partnerships have further enriched his research and have played a crucial role in the development of his innovative vaccine strategies.
Conclusion
Suraj Sable's contributions to vaccine development highlight his commitment to advancing public health through innovative research. His work exemplifies the importance of collaboration and innovation in the fight against infectious diseases.